Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Refractory Uveitis (ADUR)
NCT00348153Phase 3Unknown
- Sponsor
- Heidelberg University
- Start
- Aug 2006
- Primary completion
- Sep 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in uveitis, sponsored by Heidelberg University. Status: unknown.
02
Drugs
03
Conditions
uveitis
Beyond the preview
Go deeper on NCT00348153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348153.